Metabolic support of the enterocutaneous fistula patient

Clinics in Colon and Rectal Surgery

Volumn 23, Issue 3, 2010, Pages 142-148

  Bleier, Joshua I S ^a   Hedrick, Traci ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Enterocutaneous fistula; metabolic support; nutrition; parenteral

Indexed keywords

EID: 77956038904     PISSN: 15310043     EISSN: 15309681     Source Type: Journal    
DOI: 10.1055/s-0030-1262981     Document Type: Article

References (36)

1. Irving M, White R, Tresadern J. Three years' experience with an intestinal failure unit. Ann R Coll Surg Engl 1985 67 (1) 2-5
2. Draus J M. Jr, Huss S A., Harty N J., Cheadle W G., Larson G M. Enterocutaneous fistula: are treatments improving? Surgery 2006 140 (4) 570-576 discussion 576-578
3. Visschers R G., Olde Damink S W., van Bekkum M, Winkens B, Soeters P B., van Gemert W G. Health-related quality of life in patients treated for enterocutaneous fistula. Br J Surg 2008 95 (10) 1280-1286
4. Teixeira P G., Inaba K, Dubose J et al. Enterocutaneous fistula complicating trauma laparotomy: a major resource burden. Am Surg 2009 75 (1) 30-32
5. Trzeciak S, Dellinger R P., Abate N L. et al. Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. Chest 2006 129 (2) 225-232
6. Dellinger R P., Levy M M., Carlet J M. et al, International Surviving Sepsis Campaign Guidelines Committee American Association of Critical-Care Nurses American College of Chest Physicians American College of Emergency Physicians Canadian Critical Care Society European Society of Clinical Microbiology and Infectious Diseases European Society of Intensive Care Medicine European Respiratory Society International Sepsis Forum Japanese Association for Acute Medicine Japanese Society of Intensive Care Medicine Society of Critical Care Medicine Society of Hospital Medicine Surgical Infection Society World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008 36 (1) 296-327
7. Solomkin J S., Mazuski J E., Bradley J S. et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010 50 (2) 133-164
8. Berry S M., Fischer J E. Enterocutaneous fistulas. Curr Probl Surg 1994 31 (6) 469-566
9. Hedrick T L., Evans H L., Smith R L. et al. Can we define the ideal duration of antibiotic therapy? Surg Infect (Larchmt) 2006 7 (5) 419-432
10. Joyce M R., Dietz D W. Management of complex gastrointestinal fistula. Curr Probl Surg 2009 46 (5) 384-430
11. Schecter W P., Hirshberg A, Chang D S. et al. Enteric fistulas: principles of management. J Am Coll Surg 2009 209 (4) 484-491
12. Goverman J, Yelon J A., Platz J J., Singson R C., Turcinovic M. The fistula VAC, a technique for management of enterocutaneous fistulae arising within the open abdomen: report of 5 cases. J Trauma 2006 60 (2) 428-431 discussion 431
13. Gunn L A., Follmar K E., Wong M S., Lettieri S C., Levin L S., Erdmann D. Management of enterocutaneous fistulas using negative-pressure dressings. Ann Plast Surg 2006 57 (6) 621-625
14. Cro C, George K J., Donnelly J, Irwin S T., Gardiner K R. Vacuum assisted closure system in the management of enterocutaneous fistulae. Postgrad Med J 2002 78 (920) 364-365
15. Wainstein D E., Fernandez E, Gonzalez D, Chara O, Berkowski D. Treatment of high-output enterocutaneous fistulas with a vacuum-compaction device. A ten-year experience. World J Surg 2008 32 (3) 430-435
16. Fischer J E. A cautionary note: the use of vacuum-assisted closure systems in the treatment of gastrointestinal cutaneous fistula may be associated with higher mortality from subsequent fistula development. Am J Surg 2008 196 (1) 1-2
17. Bee T K., Croce M A., Magnotti L J. et al. Temporary abdominal closure techniques: a prospective randomized trial comparing polyglactin 910 mesh and vacuum-assisted closure. J Trauma 2008 65 (2) 337-342 discussion 342-344
18. Visschers R G., Olde Damink S W., Winkens B, Soeters P B., van Gemert W G. Treatment strategies in 135 consecutive patients with enterocutaneous fistulas. World J Surg 2008 32 (3) 445-453
19. Dudrick S J., Maharaj A R., McKelvey A A. Artificial nutritional support in patients with gastrointestinal fistulas. World J Surg 1999 23 (6) 570-576
20. Chapman R, Foran R, Dunphy J E., Foran R, Dunphy J E. Management of intestinal fistulas. Am J Surg 1964 108 157-164
21. Lloyd D A., Gabe S M., Windsor A C. Nutrition and management of enterocutaneous fistula. Br J Surg 2006 93 (9) 1045-1055
22. Stanga Z, Brunner A, Leuenberger M et al. Nutrition in clinical practice - the refeeding syndrome: illustrative cases and guidelines for prevention and treatment. Eur J Clin Nutr 2008 62 (6) 687-694
23. Paauw J D., Borders H, Ingalls N et al. The incidence of PICC line-associated thrombosis with and without the use of prophylactic anticoagulants. JPEN J Parenter Enteral Nutr 2008 32 (4) 443-447
24. Marra A R., Opilla M, Edmond M B., Kirby D F. Epidemiology of bloodstream infections in patients receiving long-term total parenteral nutrition. J Clin Gastroenterol 2007 41 (1) 19-28
25. Fiel M I., Wu H S., Iyer K, Rodriguez-Laiz G, Schiano T D. Rapid reversal of parenteral-nutrition-associated cirrhosis following isolated intestinal transplantation. J Gastrointest Surg 2009 13 (9) 1717-1723
26. Bower R H., Cerra F B., Bershadsky B et al. Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med 1995 23 (3) 436-449
27. Schilling J, Vranjes N, Fierz W et al. Clinical outcome and immunology of postoperative arginine, omega-3 fatty acids, and nucleotide-enriched enteral feeding: a randomized prospective comparison with standard enteral and low calorie/low fat i.v. solutions. Nutrition 1996 12 (6) 423-429
28. Heyland D K., Novak F, Drover J W., Jain M, Su X, Suchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001 286 (8) 944-953
29. Marik P E., Zaloga G P. Immunonutrition in critically ill patients: a systematic review and analysis of the literature. Intensive Care Med 2008 34 (11) 1980-1990
30. Lévy E, Frileux P, Cugnenc P H., Honiger J, Ollivier J M., Parc R. High-output external fistulae of the small bowel: management with continuous enteral nutrition. Br J Surg 1989 76 (7) 676-679
31. Teubner A, Morrison K, Ravishankar H R., Anderson I D., Scott N A., Carlson G L. Fistuloclysis can successfully replace parenteral feeding in the nutritional support of patients with enterocutaneous fistula. Br J Surg 2004 91 (5) 625-631
32. Nubiola-Calonge P, Badía J M., Sancho J, Gil M J., Segura M, Sitges-Serra A. Blind evaluation of the effect of octreotide (SMS 201-995), a somatostatin analogue, on small-bowel fistula output. Lancet 1987 2 (8560) 672-674
33. Scott N A., Finnegan S, Irving M H. Octreotide and postoperative enterocutaneous fistulae: a controlled prospective study. Acta Gastroenterol Belg 1993 56 (3-4) 266-270
34. Sancho J J., di Costanzo J, Nubiola P et al. Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula. Br J Surg 1995 82 (5) 638-641
35. Alvarez C, McFadden D W., Reber H A. Complicated enterocutaneous fistulas: failure of octreotide to improve healing. World J Surg 2000 24 (5) 533-537 discussion 538
36. Alivizatos V, Felekis D, Zorbalas A. Evaluation of the effectiveness of octreotide in the conservative treatment of postoperative enterocutaneous fistulas. Hepatogastroenterology 2002 49 (46) 1010-1012